Results 171 to 180 of about 61,779 (245)

Molecular types, clinical profile, and exploratory virulence-associated phenotypes of clinical Cryptococcus isolates from Amazonas, Brazil. [PDF]

Braz J Microbiol
Filho RLLR, Moreira IMB, Lazameth-Diniz NF, Souza FF, Bisneto JFDDV, de Sousa NSO, de Almeida JDR, de Souza ÉS, Cruz KS, Santos CSDS, Frickmann H, de Souza JVB.   +11 more
europepmc   +1 more source

Can Fluconazole Be Used to Treat Non-Resistant Candida (Candidozyma) auris Infections? Preclinical Pharmacokinetic/Pharmacodynamic Data From a Galleria mellonella Infection Model. [PDF]

J Infect Dis
Kroustali V, Pournaras S, Meletiadis J.
europepmc   +1 more source

Effects of the HDAC6/8 Inhibitor MC1568, Alone and in Combination With Fluconazole, in Non-Albicans Candida Species Infections. [PDF]

Microbiologyopen
Giammarino A, Lambona C, Raucci A, Simonetti G, Macrì S, Iuzzolino A, Trisciuoglio D, Valente S, Giusiano G, Angiolella L, Mai A.   +10 more
europepmc   +1 more source

Discovery of a Caffeic Acid Thioamide with Potent Activity against Pathogenic Fungi and Fluconazole Tolerance-Eliminating Effects in <i>Candida albicans</i>. [PDF]

Drug Des Devel Ther
Wang J, Guo Q, Chen N, Jiang Y, Zhang D, Ni T.   +5 more
europepmc   +1 more source

First Case of Candidemia With Fluconazole-Resistant <i>Candida albicans</i> and Y132H Mutations in <i>ERG11</i> Gene From Pakistan. [PDF]

Case Rep Infect Dis
Nasir N, Farooqi J, Khanum I, Zaka S, Batool S, Ghanchi N, Jabeen K.   +6 more
europepmc   +1 more source

Population Pharmacokinetic Modeling of Intravenous Fluconazole to Inform eGFR-Based Dosing: A Simulation Study Demonstrating Superiority over Standard Regimens. [PDF]

Pharmaceutics
Macková T, Vodička M, Slanař O, Šíma M.   +3 more
europepmc   +1 more source